{"ALNY": {"Ticker": "ALNY", "Company": "32", "Sector": "dfs", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$210 to $178"}, {"Date": "2022-03-01", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$223"}, {"Date": "2022-02-03", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": "$170"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Guggenheim", "Morgan Stanley", "Citigroup"], "Price_Target": 190.33}, "AMD": {"Ticker": "AMD", "Company": "Advanced Micro Devices", "Sector": "Information Technology", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Strong Buy", "Target_Change": "$160"}, {"Date": "2022-03-31", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$148 to $115"}, {"Date": "2022-02-22", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$150"}, {"Date": "2022-02-09", "Rating": "Upgrade", "Organization": "Daiwa Securities", "Rating_Change": "Outperform to Buy", "Target_Change": "$140 to $150"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$175 to $180"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$180 to $200"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$140 to $160"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$150 to $160"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$155 to $165"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$135 to $140"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$120 to $140"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Craig Hallum", "Rating_Change": "Buy", "Target_Change": "$150 to $160"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$150 to $160"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$175 to $190"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$145 to $155"}], "Score": 1.13, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 15, "Period": "180 days", "Analists": ["BofA Securities", "Susquehanna", "Rosenblatt", "Mizuho", "Barclays", "Raymond James", "JP Morgan", "Cowen", "Jefferies", "KeyBanc Capital Markets", "Craig Hallum", "Deutsche Bank", "Bernstein", "Daiwa Securities"], "Price_Target": 159.0}, "A": {"Ticker": "A", "Company": "Agilent Technologies", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$130"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$180 to $160"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$169 to $145"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$170 to $155"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$187 to $178"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$190 to $175"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$179 to $160"}], "Score": 1.14, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 7, "Period": "180 days", "Analists": ["BofA Securities", "Wells Fargo", "Cowen", "Evercore ISI", "Stifel", "Citigroup"], "Price_Target": 157.57}, "T": {"Ticker": "T", "Company": "AT&T", "Sector": "Communication Services", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Resumed", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$23"}, {"Date": "2022-04-11", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$34 to $22"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$29 to $27"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$27 to $26"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$34 to $32"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$37 to $30"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$33 to $29"}], "Score": 1.14, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 7, "Period": "180 days", "Analists": ["Wells Fargo", "JP Morgan", "Cowen", "Goldman", "Deutsche Bank", "UBS", "Wolfe Research"], "Price_Target": 27.0}, "TECH": {"Ticker": "TECH", "Company": "Bio-Techne", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$370"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Wells Fargo"], "Price_Target": 370.0}, "CRL": {"Ticker": "CRL", "Company": "Charles River Laboratories", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$370 to $280"}, {"Date": "2022-04-07", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$377"}, {"Date": "2022-02-17", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$400"}, {"Date": "2022-02-17", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$465 to $420"}, {"Date": "2022-02-17", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$465 to $430"}, {"Date": "2022-02-17", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$409 to $350"}, {"Date": "2022-02-17", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$445 to $400"}], "Score": 1.57, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 7, "Period": "180 days", "Analists": ["BofA Securities", "Morgan Stanley", "Stephens", "Jefferies", "Deutsche Bank", "UBS", "Citigroup"], "Price_Target": 379.57}, "CTRA": {"Ticker": "CTRA", "Company": "Coterra", "Sector": "Energy", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Susquehanna", "Rating_Change": "Positive to Neutral", "Target_Change": "$26 to $32"}, {"Date": "2022-03-10", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$25 to $26"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Susquehanna", "Piper Sandler"], "Price_Target": 29.0}, "DHR": {"Ticker": "DHR", "Company": "Danaher Corporation", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$265"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Wells Fargo"], "Price_Target": 265.0}, "DE": {"Ticker": "DE", "Company": "Deere & Co.", "Sector": "Industrials", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$475 to $450"}, {"Date": "2022-03-28", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": "$355 to $440"}, {"Date": "2022-03-11", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$455"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["BofA Securities", "Wells Fargo", "JP Morgan"], "Price_Target": 448.33}, "GPS": {"Ticker": "GPS", "Company": "Gap", "Sector": "Consumer Discretionary", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": "$22"}, {"Date": "2022-04-18", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$14"}, {"Date": "2022-04-01", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$17 to $13"}, {"Date": "2022-03-09", "Rating": "Downgrade", "Organization": "Daiwa Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$13.75"}, {"Date": "2022-02-15", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$26 to $14"}, {"Date": "2022-02-03", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$15"}], "Score": -0.83, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 6, "Period": "180 days", "Analists": ["Guggenheim", "BofA Securities", "Morgan Stanley", "Barclays", "Daiwa Securities"], "Price_Target": 12.0}, "HOLX": {"Ticker": "HOLX", "Company": "Hologic", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$75"}, {"Date": "2022-04-04", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$80"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Wells Fargo", "Evercore ISI"], "Price_Target": 77.5}, "HBAN": {"Ticker": "HBAN", "Company": "Huntington Bancshares", "Sector": "Financials", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Stephens", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$16 to $17"}, {"Date": "2022-04-08", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$16"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["BofA Securities", "Stephens"], "Price_Target": 16.5}, "IQV": {"Ticker": "IQV", "Company": "IQVIA", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$235"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Wells Fargo"], "Price_Target": 235.0}, "K": {"Ticker": "K", "Company": "Kellogg's", "Sector": "Consumer Staples", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$74 to $73"}, {"Date": "2022-03-30", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$73"}, {"Date": "2022-02-11", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Underweight", "Target_Change": "$64 to $57"}, {"Date": "2022-01-31", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$75 to $70"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Deutsche Bank", "BMO Capital Markets", "JP Morgan", "UBS"], "Price_Target": 68.25}, "MRO": {"Ticker": "MRO", "Company": "Marathon Oil", "Sector": "Energy", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Susquehanna", "Rating_Change": "Neutral to Positive", "Target_Change": "$32"}, {"Date": "2022-03-02", "Rating": "Downgrade", "Organization": "The Benchmark Company", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-02-23", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$22 to $27"}, {"Date": "2022-02-18", "Rating": "Upgrade", "Organization": "Scotiabank", "Rating_Change": "Sector Perform to Sector Outperform", "Target_Change": "$28"}], "Score": 0.75, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Susquehanna", "The Benchmark Company", "Piper Sandler", "Scotiabank"], "Price_Target": 20.75}, "MTD": {"Ticker": "MTD", "Company": "Mettler Toledo", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": ""}, {"Date": "2022-03-10", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$1240"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Goldman", "Wells Fargo"], "Price_Target": 619.0}, "NEM": {"Ticker": "NEM", "Company": "Newmont", "Sector": "Materials", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$57"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "National Bank Financial", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$94.28"}, {"Date": "2022-04-19", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": ""}, {"Date": "2022-02-09", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$65"}], "Score": -1.75, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Credit Suisse", "Bernstein", "National Bank Financial", "Canaccord Genuity"], "Price_Target": 28.5}, "PENN": {"Ticker": "PENN", "Company": "Penn National Gaming", "Sector": "Consumer Discretionary", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$55 to $51"}, {"Date": "2022-02-09", "Rating": "Upgrade", "Organization": "Susquehanna", "Rating_Change": "Neutral to Positive", "Target_Change": "$34 to $65"}, {"Date": "2022-02-04", "Rating": "Upgrade", "Organization": "Loop Capital", "Rating_Change": "Sell to Hold", "Target_Change": "$53 to $49"}, {"Date": "2022-02-04", "Rating": "Downgrade", "Organization": "ROTH Capital", "Rating_Change": "Buy to Neutral", "Target_Change": "$79 to $51"}, {"Date": "2022-01-26", "Rating": "Upgrade", "Organization": "Macquarie", "Rating_Change": "Neutral to Outperform", "Target_Change": "$80 to $71"}], "Score": 1.2, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Analists": ["Morgan Stanley", "Susquehanna", "Macquarie", "Loop Capital", "ROTH Capital"], "Price_Target": 57.4}, "TMO": {"Ticker": "TMO", "Company": "Thermo Fisher Scientific", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$525"}, {"Date": "2022-01-26", "Rating": "Resumed", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$700"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Wells Fargo", "Barclays"], "Price_Target": 612.5}, "TWTR": {"Ticker": "TWTR", "Company": "Twitter", "Sector": "Communication Services", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-04-21", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$50"}, {"Date": "2022-04-20", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$41 to $50"}, {"Date": "2022-04-19", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$48"}, {"Date": "2022-04-14", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Hold to Sell", "Target_Change": ""}, {"Date": "2022-04-14", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-04-05", "Rating": "Downgrade", "Organization": "MKM Partners", "Rating_Change": "Buy to Neutral", "Target_Change": "$49"}, {"Date": "2022-03-11", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$35"}, {"Date": "2022-03-01", "Rating": "Initiated", "Organization": "The Benchmark Company", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$52 to $45"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Neutral", "Target_Change": "$46 to $42"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$85 to $50"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Neutral", "Target_Change": "$80 to $46"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$54 to $46"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$80 to $60"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$57 to $59"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$56 to $46"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$79 to $54"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$55 to $40"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$64 to $34"}, {"Date": "2022-02-01", "Rating": "Resumed", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$39"}], "Score": -0.14, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 21, "Period": "180 days", "Analists": ["Morgan Stanley", "Susquehanna", "Wolfe Research", "Wedbush", "Stifel", "Deutsche Bank", "Citigroup", "Robert W. Baird", "Rosenblatt", "KeyBanc Capital Markets", "The Benchmark Company", "BMO Capital Markets", "Piper Sandler", "BofA Securities", "Truist", "Mizuho", "Barclays", "Loop Capital", "MKM Partners", "Oppenheimer"], "Price_Target": 33.76}, "TYL": {"Ticker": "TYL", "Company": "Tyler Technologies", "Sector": "Information Technology", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$405"}, {"Date": "2022-04-18", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$520"}, {"Date": "2022-03-14", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$445"}, {"Date": "2022-02-09", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$550"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Loop Capital", "Truist", "Wells Fargo", "Barclays"], "Price_Target": 480.0}, "VZ": {"Ticker": "VZ", "Company": "Verizon Communications", "Sector": "Communication Services", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Neutral", "Target_Change": "$61 to $55"}, {"Date": "2022-01-26", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$62 to $56"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Goldman", "JP Morgan"], "Price_Target": 55.5}, "WAT": {"Ticker": "WAT", "Company": "Waters Corporation", "Sector": "Health Care", "Updated": "2022-04-25", "Rating": [{"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$320 to $315"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Wells Fargo"], "Price_Target": 315.0}}